Press release
Ovarian Cancer Drug Pipeline Review H1 2017
For More on Ovarian Cancer Pipeline Review H1 2017 Report Inquire @
https://tinyurl.com/Ovarian-Cancer-Pipeline .
Report Description:
The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 2, 15, 135, 128, 7, 208, 21 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 11, 14, 43 and 8 molecules, respectively.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Ovarian Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Get Discount On Report@ https://tinyurl.com/Ovarian-Cancer-Therapeutics .
Report Includes Ovarian Cancer Pipeline by:
2cureX ApS, 3-V Biosciences Inc, 3SBio Inc, 4SC AG, AB Science SA, AbbVie Inc, AbGenomics International Inc, Adamed Sp z oo, Aduro BioTech Inc, Advenchen Laboratories LLC, Alchemia Ltd, Allinky Biopharma, amcure GmbH, Amgen Inc, Antibe Therapeutics Inc, APEIRON Biologics AG, Apexigen Inc, Aphios Corp, Aposense Ltd, ARMO Biosciences Inc, ArQule Inc, Array BioPharma Inc, Asana BioSciences LLC, Aslan Pharmaceuticals Pte Ltd, Astellas Pharma Inc, Astex Pharmaceuticals Inc, AstraZeneca Plc, Aurobindo Pharma Ltd, AVEO Pharmaceuticals Inc, B Cell Design SAS, Basilea Pharmaceutica Ltd, Bavarian Nordic A/S, Bayer AG, BeiGene (Beijing) Co Ltd, Beijing Hanmi Pharmaceutical Co Ltd, BeyondSpring Pharmaceuticals Inc, Biocon Ltd, Bionomics Ltd, Bionovis SA, Biotecnol Ltd, Biothera Pharmaceutical Inc, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Company, Burzynski Research Institute Inc, Calithera Biosciences Inc, Cancer Prevention Pharmaceuticals Inc, Carna Biosciences Inc, Cascadian Therapeutics Inc, CBT Pharmaceuticals Inc, CCRP Therapeutics GmbH, Celgene Corp, Celldex Therapeutics Inc, Cellectar Biosciences Inc, Celleron Therapeutics Ltd, Celltrion Inc, Celyad SA, Chipscreen Biosciences Ltd, ChoDang Pharm Co Ltd, Chong Kun Dang Pharmaceutical Corp, Cipla Ltd, Cleave Biosciences Inc, Cleveland BioLabs Inc, COARE Biotechnology Inc, Coherus BioSciences Inc, Compugen Ltd, Conatus Pharmaceuticals Inc, Confluence Life Sciences Inc, Corvus Pharmaceuticals Inc, Critical Outcome Technologies Inc, CrystalGenomics Inc, Daiichi Sankyo Company Ltd, DanDrit Biotech A/S, Deciphera Pharmaceuticals LLC, Dicerna Pharmaceuticals Inc, Dr. Reddy's Laboratories Ltd, Eisai Co Ltd, Eli Lilly and Company, Endor Nanotechnologies SL, EnGeneIC Ltd, Ensol Biosciences Inc, EntreChem SL, Enzene Biosciences Ltd, Enzo Biochem Inc, EpiThany Inc, Etubics Corp, Exelixis Inc, Exicure Inc, F-star Biotechnology Ltd, F. Hoffmann-La Roche Ltd, Formosa Laboratories Inc, Forty Seven Inc, Fusion Antibodies Ltd, Gene Techno Science Co Ltd, Genentech Inc, Genor BioPharma Co Ltd, Genoscience Pharma, Genzyme Corp, Gilead Sciences Inc, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Glycostem Therapeutics BV, Glycotope GmbH, Green Cross Corp, Hadasit Medical Research Services & Development Ltd, Handok Inc, Hanmi Pharmaceuticals Co Ltd, Heat Biologics Inc, Hemispherx Biopharma Inc, Humorigin Biotechnology Corp, Hutchison China MediTech Ltd, iDD biotech SAS, Ideaya Biosciences Inc, Ignyta Inc, Ildong Pharmaceutical Co Ltd, Immodulon Therapeutics Ltd, ImmuneXcite Inc, Immunomedics Inc, Immunovative Therapies Ltd, Incanthera Ltd, Incyte Corp, Innovation Pharmaceuticals Inc, Innovent Biologics Inc, Inovio Pharmaceuticals Inc, Interprotein Corp, Intezyne Technologies Inc, Ionis Pharmaceuticals Inc, Isofol Medical AB, Jeil Pharmaceutical Co Ltd, JHL Biotech Inc, Jiangsu Hengrui Medicine Co Ltd, Johnson & Johnson, KaloBios Pharmaceuticals Inc, Kancera AB, Karyopharm Therapeutics Inc, Kura Oncology Inc, Laboratorio ELEA SACIF y A, Lion Biotechnologies Inc, LipoMedix Pharmaceutical Inc, Lipopharma Therapeutics SL, Loxo Oncology Inc, Mabion SA, MacroGenics Inc, Mantis Therapeutics BV, Marina Biotech Inc, MediaPharma Srl, MedImmune LLC, Medinet Co Ltd, Merck & Co Inc, Merck KGaA, Merrimack Pharmaceuticals Inc, Merus NV, Microlin Bio Inc, Molecular Partners AG, MolMed SpA, Mologen AG, Morphotek Inc, Multimmune GmbH, Mycenax Biotech Inc, NantKwest Inc, Natco Pharma Ltd, NatureWise Biotech & Medicals Corp, Nektar Therapeutics, Neovacs SA, Nerviano Medical Sciences Srl, Nippon Kayaku Co Ltd, NormOxys Inc, Northwest Biotherapeutics Inc, Novartis AG, Novogen Ltd, Noxxon Pharma AG, NuCana BioMed Ltd, OBI Pharma Inc, Omnitura Therapeutics Inc, Oncobiologics Inc, Oncology Research International Ltd, Oncolytics Biotech Inc, OncoMed Pharmaceuticals Inc, Onconova Therapeutics Inc, Ono Pharmaceutical Co Ltd, Oryx GmbH & Co KG, Otsuka Holdings Co Ltd, Oxford BioMedica Plc, Pfizer Inc, Pharma Mar SA, PharmAbcine Inc, Pivotal BioSciences Inc, PlantForm Corp, Plexxikon Inc, PLx Pharma Inc, Precision Biologics Inc, Prima BioMed Ltd, Propanac Biopharma Inc, Provectus Biopharmaceuticals Inc, PsiOxus Therapeutics Ltd, Puma Biotechnology Inc, Puretech Health plc, Quintessence Biosciences Inc, R Pharm, Rafael Pharmaceuticals Inc, RedHill Biopharma Ltd, Redx Pharma Plc, Rexahn Pharmaceuticals Inc, Rgenix Inc, Rhizen Pharmaceuticals SA, Richter Gedeon Nyrt, Samumed LLC, Sanofi, Selvita SA, Siamab Therapeutics Inc, Sichuan Kelun Pharmaceutical Co Ltd, Sigma-Tau SpA, Sigmoid Pharma Ltd, Sillajen Biotherapeutics, Simcere Pharmaceutical Group, Sorrento Therapeutics Inc, Steba Biotech SA, Sumitomo Dainippon Pharma Co Ltd, SuviCa Inc, Symphogen A/S, SynDevRx Inc, Synermore Biologics Co Ltd, Taiho Pharmaceutical Co Ltd, TaiwanJ Pharmaceuticals Co Ltd, Takeda Pharmaceutical Company Ltd, Targovax ASA, Tarrex Biopharma Ltd, Tiltan Pharma Ltd, Tocagen Inc, TRACON Pharmaceuticals Inc, Transgene SA, United BioPharma Inc, Vaccinex Inc, VasGene Therapeutics Inc, Vaximm AG, ViiV Healthcare Ltd, Vitality Biopharma Inc, Wellstat Biologics Corp, Wilex AG, WntResearch AB, Wuhan YZY Biopharma Co Ltd, XBiotech Inc, XuanZhu Pharma Co Ltd, Yabao Pharmaceutical Group Co Ltd, Zymeworks In.
Scope:
-The pipeline guide provides a snapshot of the global therapeutic landscape of Ovarian Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Ovarian Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ovarian Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ovarian Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Ovarian Cancer (Oncology).
Purchase This Report at: https://tinyurl.com/Ovarian-Cancer-Drugs .
Major Table of Content:
• Introduction
• Ovarian Cancer - Overview
• Ovarian Cancer - Therapeutics Development
• Ovarian Cancer - Therapeutics Assessment
• Ovarian Cancer - Companies Involved in Therapeutics Development
• Ovarian Cancer - Drug Profiles
• Ovarian Cancer - Dormant Projects
• Ovarian Cancer - Discontinued Products
• Ovarian Cancer - Product Development Milestones.
Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
India.
Tel: + 1 888 391 5441
E-mail: sales@reportsnreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Drug Pipeline Review H1 2017 here
News-ID: 612678 • Views: …
More Releases from ReportsandReports
The Growing Importance of Smart Wearable Equipment - Global Market: Today's Worl …
The report presents detailed information regarding the prominent players and potential competitors in the Smart Wearable Equipment - Global market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses…
Vegetable Glycerin - Global Market 2023 Driving Factors Forecast Research 2029
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Vegetable Glycerin - Global market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial role…
Underground Concrete - Global Market Booming Worldwide with Latest Trend and Fut …
The report presents detailed information regarding the prominent players and potential competitors in the Underground Concrete - Global market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue,…
Eucalyptol - Global Market was Led by the Solution Category
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Eucalyptol - Global market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial role in…
More Releases for Bio
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics…
Worldwide Bio-Electronics Market 2025 – Global Analysis and Forecasts by Type …
Bio-Electronics is defined as the electronic devices used for bio-medical purposes, and helps in creating and evaluating the new technologies for better understanding of biological systems. The increasing demand of bio-electronics to meet the overwhelming need in healthcare industry will boost the bio-electronics market in forecast period. Furthermore, the growth in research of implantable devices for developing robust and reliable implantable medical devices will increase the demand of bio-electronics in…
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description:
The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are…
